FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386897000: Lamivudine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461075018 Lamivudine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481011010 Lamivudine en Synonym Active Entire term case insensitive SNOMED CT core module
1491831012 3TC en Synonym Active Only initial character case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine Is a Substance with reverse transcriptase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Lamivudine Is a Allergen class false Inferred relationship Existential restriction modifier
Lamivudine Is a Drug allergen false Inferred relationship Existential restriction modifier
Lamivudine Has disposition Reverse transcriptase inhibitor true Inferred relationship Existential restriction modifier
Lamivudine Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Lamivudine Is a Substance with transferase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Lamivudine Is a Pyrimidine true Inferred relationship Existential restriction modifier
Lamivudine Is a Nucleoside analog true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing efavirenz and lamivudine and tenofovir (medicinal product) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing only efavirenz and lamivudine and tenofovir (medicinal product) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing efavirenz and lamivudine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing only efavirenz and lamivudine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely abacavir (as abacavir sulfate) 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir (as abacavir sulfate) 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 2
Product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing only dolutegravir and lamivudine and tenofovir (medicinal product) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing dolutegravir and lamivudine and tenofovir (medicinal product) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine Inferred relationship Existential restriction modifier 1
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Lamivudine Inferred relationship Existential restriction modifier 1
Measurement of lamivudine (procedure) Component False Lamivudine Inferred relationship Existential restriction modifier
Measurement of lamivudine (procedure) Component True Lamivudine Inferred relationship Existential restriction modifier 2
Measurement of lamivudine (procedure) Component False Lamivudine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 150mg tablet - product Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 10mg/mL oral solution - product Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine+zidovudine 150mg/300mg tablet - product Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 5mg/1mL oral solution - product Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablet - product Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Epivir 300mg tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Epivir 150mg tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Epivir 10mg/mL oral solution Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Combivir tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zeffix 5mg/1mL oral solution Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Amarox Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Amarox Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Amarox Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Amarox Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Generic Trizivir tablets Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 100 milligram/1 each conventional release oral tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Dolutegravir 50mg / Lamivudine 300mg tablets 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Dovato 50mg/300mg tablets (ViiV Healthcare UK Ltd) 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Dovato 50mg/300mg tablets (ViiV Healthcare UK Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (CST Pharma Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets Has specific active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Epivir 300mg tablets (GlaxoSmithKline) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Epivir 150mg tablets (GlaxoSmithKline) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Epivir 50mg/5ml oral solution (GlaxoSmithKline) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Combivir tablets (GlaxoSmithKline) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Trizivir tablets (GlaxoSmithKline) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Zeffix 5mg/ml oral solution (GlaxoSmithKline) Has active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Kivexa 600mg/300mg tablets (GlaxoSmithKline) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (PI) (Dowelhurst Ltd) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (PI) (Waymade Ltd) Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (PI) (Dowelhurst Ltd) 28 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (PI) (Waymade Ltd) 28 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets 60 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 50mg/5ml oral solution 240 ml Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 300mg tablets 30 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets 28 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Zidovudine 300mg / Lamivudine 150mg tablets 60 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Generic Trizivir tablets 60 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 25mg/5ml oral solution 240 ml Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets 30 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Milpharm Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Milpharm Ltd) 30 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Medihealth (Northern) Ltd) Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Medihealth (Northern) Ltd) 28 tablet Has specific active ingredient True Lamivudine Inferred relationship Existential restriction modifier
Epivir 300mg tablets (GlaxoSmithKline) 30 tablet Has active ingredient False Lamivudine Inferred relationship Existential restriction modifier

Start Page 2 of 4 Next End


This concept is not in any reference sets

Back to Start